Human immunodeficiency virus (HIV) controllers are patients who control viral replication without antiretroviral therapy. We present the case of an HIV controller who had CD4 and CD8 coexpressed on 40% of his T cells. Although a recent study found that double-positive T cells had superior antiviral capacity in HIV-1 controllers, in this case, the CD4 + CD8 + T cells did not have strong antiviral activity.
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Human immunodeficiency virus (HIV) controllers are patients who control viral replication without antiretroviral therapy [1] . We present the case of an HIV controller who had CD4 and CD8 coexpressed on 40% of his T cells. Although a recent study found that double-positive T cells had superior antiviral capacity in HIV-1 controllers [2] , in this case, the CD4 + CD8 + T cells did not have strong antiviral activity.
CASE PRESENTATION
The patient is a 62-year-old African American male with human immunodeficiency virus (HIV) infection diagnosed 12 years ago. His CD4 count was 711 cells/µL, and his viral load was 141 copies/mL plasma without antiretroviral therapy (ART) at diagnosis. His viral load remained undetectable to low (<400 copies/mL), and although his absolute CD4 count was very high, his CD4 + T cell percentage was low and his CD8 + T cell percentage was elevated ( Figure 1A ). Figure 1E ). To determine whether the cells were HIV-1 specific, they were stimulated with HIV-1 antigens. A similar proportion of all 3 cell populations expressed TNF-α in response to stimulation with Gag peptides ( Although we were not able to determine the etiology of the mutual expression of CD4 and CD8 on T cells, flow cytometry revealed that the majority of these CD4 + CD8
+ T cells were effector memory cells with an activated phenotype. Human immunodeficiency virus controllers generally have higher levels of activated CD8 + T cells [5] , elevated inflammatory biomarkers [6, 7] , and higher rates of atherosclerosis [8, 9] compared with treated and uninfected individuals. The significance of this inflammation is an active area of investigation. A recent study reported HIV controllers have higher rates of hospitalization than treated patients [10] . Preliminary studies suggest that ART decreases immune activation in some HIV controllers [11] [12] [13] . Randomized controlled trials are needed to determine the impact of ART and/or anti-inflammatory treatment in HIV controllers. 
